Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Int Urogynecol J. 2019 Nov 26;31(7):1305–1313. doi: 10.1007/s00192-019-04120-7

Table 1.

Participant demographic, clinical and perioperative characteristics

Characteristic Intention to Treat
Per Protocol Analysis
Bowel Prep n=43 (%) No Prep n=52 (%) Bowel Prep n=50 (%) No Prep n=45 (%)
Agea (y) 59.5±6.0 60.7±6.7 60.0±6.1 60.3±6.7
BMIa (kg/m2) 27.4±4.6 26.6±4.8 27.1±3.9 26.9±5.5
Gravidityb 2 (2, 4) 3 (2, 4) 3 (2, 4) 3 (2, 4)
Parityb 2 (2, 3) 2.5 (2, 3) 2 (2, 3) 2 (2, 3)
Current smoker 4 (9.3%) 3 (5.8%) 4 (8.0%) 3 (6.7%)
Post-menopause 41 (95.3%) 49 (94.2%) 47 (94.0%) 43 (95.6%)
Prior hysterectomy 14 (32.6%) 17 (32.7%) 20 (40.0%) 34 (75.6%)
Stage of prolapse
 II 2 (4.7%) 9 (17.3%) 7 (14.0%) 4 (8.9%)
 III 39 (90.7%) 39 (75.0%) 40 (80.0%) 38 (84.4%)
 IV 2 (4.7%) 4 (7.7%) 3 (6.0%) 3 (6.7%)
Self-reported baseline constipation* 8 (18.6%) 16 (30.8%) 14 (28.0%) 10 (22.2%)
Laparoscopic sacrocolpopexy 37 (86.1%) 47 (90.4%) 47 (94.0%) 37 (82.2%)
Robotic-assisted sacrocolpopexy 5 (11.6%) 5 (9.6%) 3 (6.0%) 7 (15.6%)
Supracervical hysterectomy 28 (65.1%) 33 (63.5%) 29 (58.0%) 32 (71.1%)
Midurethral sling 2 (4.7%) 4 (7.7%) 3 (6.0%) 3 (6.7%)
Length of staya (days) 1.1±1.0 1.0±0.4 1.1±0.9 1.0±0.4
Operative timea (min) 214.3±60.2 204.1±52.9 206.7±53.1 210.0±60.0
Estimated blood lossa,c (ml) 50.7±48.5 57.2±63.2 43.9±36.2 65.8±72.0
Intra-operative complications 4 (9.3%) 3 (5.8%) 3 (6.0%) 4 (8.9%)
Post-operative complications 7 (16.3%) 6 (11.5%) 5 (10.0%) 8 (17.8%)
Readmission 0 (0.0%) 2 (3.9%) 1 (2.0%) 1 (2.2%)

With the exception of EBL, all p-values >0.05

a

Data are presented as mean ± SD

b

Data are presented as median (IQR)

c

p=.036 for per protocol analysis

*

Self-reported baseline constipation was obtained from pre-operative 7-day bowel diary